Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high-risk KMT2A-rearranged acute myeloid leukaemia.

IF 3.8 2区医学 Q1 HEMATOLOGY

British Journal of Haematology Pub Date : 2025-09-21 DOI:10.1111/bjh.70183

Arundhati Chavan, Brendan Frett, Daniel T Armstrong, Baku Acharya, Pamela Lockyer, Marjan Boerma, Samrat Roy Choudhury

引用次数: 0

查看原文本刊更多论文

高危kmt2a重排急性髓性白血病RET受体酪氨酸激酶的表观遗传失调和治疗靶向

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

British Journal of Haematology 医学-血液学

CiteScore

8.60

自引率

4.60%

发文量

565

审稿时长

1 months

期刊介绍： The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.